CEL-SCI Corporation (CVM)
USD 0.62
(-18.09%)
USD 0.62
(-18.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 31.47 Million USD | -12.72% |
| 2022 | 36.06 Million USD | -0.36% |
| 2021 | 36.19 Million USD | 24.87% |
| 2020 | 28.98 Million USD | 43.53% |
| 2019 | 20.19 Million USD | 20.41% |
| 2018 | 16.77 Million USD | -21.4% |
| 2017 | 21.33 Million USD | -16.49% |
| 2016 | 25.55 Million USD | -25.49% |
| 2015 | 34.29 Million USD | 24.38% |
| 2014 | 27.57 Million USD | 38.78% |
| 2013 | 19.86 Million USD | 13.55% |
| 2012 | 17.49 Million USD | -7.63% |
| 2011 | 18.94 Million USD | 1.22% |
| 2010 | 18.71 Million USD | 54.65% |
| 2009 | 12.1 Million USD | 27.14% |
| 2008 | 9.51 Million USD | 1.15% |
| 2007 | 9.4 Million USD | 71.87% |
| 2006 | 5.47 Million USD | 25.83% |
| 2005 | 4.35 Million USD | -2.24% |
| 2004 | 4.45 Million USD | 1.1% |
| 2003 | 4.4 Million USD | -34.11% |
| 2002 | 6.68 Million USD | -41.42% |
| 2001 | 11.4 Million USD | 27.83% |
| 2000 | 8.92 Million USD | 11.51% |
| 1999 | 8 Million USD | 11.11% |
| 1998 | 7.2 Million USD | -16.28% |
| 1997 | 8.6 Million USD | 28.36% |
| 1996 | 6.7 Million USD | 76.32% |
| 1995 | 3.8 Million USD | -19.15% |
| 1994 | 4.7 Million USD | 161.11% |
| 1993 | 1.8 Million USD | 38.46% |
| 1992 | 1.3 Million USD | 62.5% |
| 1991 | 800 Thousand USD | 14.29% |
| 1990 | 700 Thousand USD | -30.0% |
| 1989 | 1 Million USD | -33.33% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 6.08 Million USD | -6.15% |
| 2024 Q3 | 5.68 Million USD | 9.58% |
| 2024 Q1 | 6.48 Million USD | -13.15% |
| 2023 Q2 | 8.17 Million USD | 6.87% |
| 2023 Q4 | 7.46 Million USD | -8.73% |
| 2023 Q3 | 8.18 Million USD | 0.07% |
| 2023 FY | 31.47 Million USD | -12.72% |
| 2023 Q1 | 7.65 Million USD | -14.5% |
| 2022 Q3 | 8.71 Million USD | -8.72% |
| 2022 Q1 | 8.84 Million USD | 4.36% |
| 2022 Q2 | 9.55 Million USD | 8.01% |
| 2022 FY | 36.06 Million USD | -0.36% |
| 2022 Q4 | 8.94 Million USD | 2.62% |
| 2021 Q1 | 8.73 Million USD | 1.36% |
| 2021 Q2 | 8.53 Million USD | -2.27% |
| 2021 Q3 | 10.45 Million USD | 22.54% |
| 2021 FY | 36.19 Million USD | 24.87% |
| 2021 Q4 | 8.47 Million USD | -18.96% |
| 2020 Q4 | 8.61 Million USD | 24.66% |
| 2020 FY | 28.98 Million USD | 43.53% |
| 2020 Q3 | 6.9 Million USD | 3.71% |
| 2020 Q2 | 6.66 Million USD | -2.03% |
| 2020 Q1 | 6.8 Million USD | 20.48% |
| 2019 FY | 20.19 Million USD | 20.41% |
| 2019 Q1 | 5.03 Million USD | 40.44% |
| 2019 Q2 | 4.3 Million USD | -14.46% |
| 2019 Q3 | 5.21 Million USD | 20.98% |
| 2019 Q4 | 5.64 Million USD | 8.33% |
| 2018 Q2 | 4.2 Million USD | -14.37% |
| 2018 Q1 | 4.91 Million USD | 113.06% |
| 2018 Q3 | 4.07 Million USD | -3.22% |
| 2018 FY | 16.77 Million USD | -21.4% |
| 2018 Q4 | 3.58 Million USD | -11.93% |
| 2017 Q2 | 8.38 Million USD | 54.82% |
| 2017 FY | 21.33 Million USD | -16.49% |
| 2017 Q4 | 2.3 Million USD | -55.97% |
| 2017 Q1 | 5.41 Million USD | -23.89% |
| 2017 Q3 | 5.23 Million USD | -37.55% |
| 2016 FY | 25.55 Million USD | -25.49% |
| 2016 Q1 | 5.78 Million USD | -30.66% |
| 2016 Q4 | 7.11 Million USD | 11.45% |
| 2016 Q3 | 6.38 Million USD | 1.74% |
| 2016 Q2 | 6.27 Million USD | 8.48% |
| 2015 Q4 | 8.33 Million USD | 1.69% |
| 2015 FY | 34.29 Million USD | 24.38% |
| 2015 Q1 | 9.99 Million USD | 17.43% |
| 2015 Q3 | 8.2 Million USD | 5.7% |
| 2015 Q2 | 7.75 Million USD | -22.37% |
| 2014 FY | 27.57 Million USD | 38.78% |
| 2014 Q2 | 6.22 Million USD | 4.92% |
| 2014 Q3 | 6.9 Million USD | 10.84% |
| 2014 Q4 | 8.51 Million USD | 23.34% |
| 2014 Q1 | 5.93 Million USD | 17.01% |
| 2013 Q2 | 4.23 Million USD | -15.95% |
| 2013 FY | 19.86 Million USD | 13.55% |
| 2013 Q4 | 5.07 Million USD | -8.01% |
| 2013 Q3 | 5.51 Million USD | 30.03% |
| 2013 Q1 | 5.04 Million USD | 13.82% |
| 2012 Q1 | 4.44 Million USD | 14.99% |
| 2012 Q4 | 4.43 Million USD | 4.33% |
| 2012 Q3 | 4.24 Million USD | -2.77% |
| 2012 Q2 | 4.36 Million USD | -1.78% |
| 2012 FY | 17.49 Million USD | -7.63% |
| 2011 Q1 | 4.97 Million USD | -11.95% |
| 2011 Q4 | 3.86 Million USD | -21.62% |
| 2011 Q2 | 5.14 Million USD | 3.25% |
| 2011 FY | 18.94 Million USD | 1.22% |
| 2011 Q3 | 4.93 Million USD | -4.0% |
| 2010 Q2 | 5.35 Million USD | 24.94% |
| 2010 Q1 | 4.28 Million USD | 9.25% |
| 2010 Q3 | 3.42 Million USD | -35.99% |
| 2010 Q4 | 5.65 Million USD | 65.11% |
| 2010 FY | 18.71 Million USD | 54.65% |
| 2009 Q4 | 3.92 Million USD | 6.28% |
| 2009 Q3 | 3.68 Million USD | 70.59% |
| 2009 Q2 | 2.16 Million USD | -7.17% |
| 2009 FY | 12.1 Million USD | 27.14% |
| 2009 Q1 | 2.32 Million USD | -2.26% |
| 2008 FY | 9.51 Million USD | 1.15% |
| 2008 Q4 | 2.38 Million USD | 9.3% |
| 2008 Q1 | 2.86 Million USD | 44.28% |
| 2008 Q2 | 2.08 Million USD | -27.32% |
| 2008 Q3 | 2.18 Million USD | 4.56% |
| 2007 Q1 | 1.59 Million USD | -6.23% |
| 2007 FY | 9.4 Million USD | 71.87% |
| 2007 Q4 | 1.98 Million USD | -47.43% |
| 2007 Q3 | 3.78 Million USD | 85.67% |
| 2007 Q2 | 2.03 Million USD | 27.83% |
| 2006 Q2 | 1.37 Million USD | 31.03% |
| 2006 Q1 | 1.05 Million USD | 25.26% |
| 2006 FY | 5.47 Million USD | 25.83% |
| 2006 Q4 | 1.69 Million USD | 26.36% |
| 2006 Q3 | 1.34 Million USD | -2.39% |
| 2005 Q3 | 1.02 Million USD | -14.7% |
| 2005 Q2 | 1.19 Million USD | -7.08% |
| 2005 Q1 | 1.28 Million USD | 18.97% |
| 2005 FY | 4.35 Million USD | -2.24% |
| 2005 Q4 | 839.6 Thousand USD | -17.89% |
| 2004 Q4 | 1.08 Million USD | 9.64% |
| 2004 Q3 | 988.96 Thousand USD | -24.69% |
| 2004 Q2 | 1.31 Million USD | 23.46% |
| 2004 Q1 | 1.06 Million USD | -5.35% |
| 2004 FY | 4.45 Million USD | 1.1% |
| 2003 Q2 | 955.59 Thousand USD | -23.99% |
| 2003 Q1 | 1.25 Million USD | 1.84% |
| 2003 Q3 | 1.06 Million USD | 11.46% |
| 2003 FY | 4.4 Million USD | -34.11% |
| 2003 Q4 | 1.12 Million USD | 5.51% |
| 2002 Q1 | 3.05 Million USD | 16.33% |
| 2002 Q4 | 1.23 Million USD | 7.83% |
| 2002 Q3 | 1.14 Million USD | -7.83% |
| 2002 Q2 | 1.24 Million USD | -59.4% |
| 2002 FY | 6.68 Million USD | -41.42% |
| 2001 Q4 | 2.62 Million USD | 16.44% |
| 2001 Q1 | 2.79 Million USD | 47.48% |
| 2001 Q2 | 3.72 Million USD | 33.24% |
| 2001 Q3 | 2.25 Million USD | -39.31% |
| 2001 FY | 11.4 Million USD | 27.83% |
| 2000 Q2 | 2.96 Million USD | 64.65% |
| 2000 FY | 8.92 Million USD | 11.51% |
| 2000 Q1 | 1.8 Million USD | -21.74% |
| 2000 Q4 | 1.89 Million USD | -18.67% |
| 2000 Q3 | 2.32 Million USD | -21.42% |
| 1999 Q2 | 2.3 Million USD | 35.29% |
| 1999 Q3 | 1.8 Million USD | -21.74% |
| 1999 Q4 | 2.3 Million USD | 27.78% |
| 1999 FY | 8 Million USD | 11.11% |
| 1999 Q1 | 1.7 Million USD | -26.09% |
| 1998 FY | 7.2 Million USD | -16.28% |
| 1998 Q1 | 1.7 Million USD | -5.56% |
| 1998 Q2 | 1.4 Million USD | -17.65% |
| 1998 Q3 | 1.8 Million USD | 28.57% |
| 1998 Q4 | 2.3 Million USD | 27.78% |
| 1997 Q4 | 1.8 Million USD | -5.26% |
| 1997 Q2 | 3.7 Million USD | 208.33% |
| 1997 Q3 | 1.9 Million USD | -48.65% |
| 1997 FY | 8.6 Million USD | 28.36% |
| 1997 Q1 | 1.2 Million USD | -42.86% |
| 1996 Q3 | 1.6 Million USD | 23.08% |
| 1996 Q1 | 1.8 Million USD | 100.0% |
| 1996 FY | 6.7 Million USD | 76.32% |
| 1996 Q4 | 2.1 Million USD | 31.25% |
| 1996 Q2 | 1.3 Million USD | -27.78% |
| 1995 Q3 | 800 Thousand USD | -27.27% |
| 1995 Q1 | 1.1 Million USD | 0.0% |
| 1995 Q2 | 1.1 Million USD | 0.0% |
| 1995 Q4 | 900 Thousand USD | 12.5% |
| 1995 FY | 3.8 Million USD | -19.15% |
| 1994 Q2 | 1.2 Million USD | 50.0% |
| 1994 Q3 | 1.3 Million USD | 8.33% |
| 1994 Q4 | 1.1 Million USD | -15.38% |
| 1994 FY | 4.7 Million USD | 161.11% |
| 1994 Q1 | 800 Thousand USD | 161.54% |
| 1993 Q1 | 400 Thousand USD | -20.0% |
| 1993 Q4 | -1.3 Million USD | -285.71% |
| 1993 Q2 | 300 Thousand USD | -25.0% |
| 1993 FY | 1.8 Million USD | 38.46% |
| 1993 Q3 | 700 Thousand USD | 133.33% |
| 1992 Q4 | 500 Thousand USD | 66.67% |
| 1992 Q1 | 200 Thousand USD | -33.33% |
| 1992 Q2 | 300 Thousand USD | 50.0% |
| 1992 FY | 1.3 Million USD | 62.5% |
| 1992 Q3 | 300 Thousand USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 200.0% |
| 1991 Q1 | 100 Thousand USD | -66.67% |
| 1991 FY | 800 Thousand USD | 14.29% |
| 1990 FY | 700 Thousand USD | -30.0% |
| 1990 Q4 | 300 Thousand USD | 200.0% |
| 1990 Q3 | 100 Thousand USD | -50.0% |
| 1990 Q2 | 200 Thousand USD | 100.0% |
| 1990 Q1 | 100 Thousand USD | -80.0% |
| 1989 Q3 | 100 Thousand USD | 0.0% |
| 1989 Q4 | 500 Thousand USD | 400.0% |
| 1989 Q2 | - USD | -100.0% |
| 1989 Q1 | 200 Thousand USD | 113.33% |
| 1989 FY | 1 Million USD | -33.33% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 32.07 Million USD | 1.87% |
| Ampio Pharmaceuticals, Inc. | 9.26 Million USD | -239.621% |
| Armata Pharmaceuticals, Inc. | 11.64 Million USD | -170.204% |
| Actinium Pharmaceuticals, Inc. | 52 Million USD | 39.47% |
| Azitra, Inc. | 8.3 Million USD | -279.12% |
| Can-Fite BioPharma Ltd. | 8.93 Million USD | -252.16% |
| Chromocell Therapeutics Corporation | 6.86 Million USD | -358.682% |
| Calidi Biotherapeutics, Inc. | 28.99 Million USD | -8.568% |
| iBio, Inc. | 16.85 Million USD | -86.702% |
| Lineage Cell Therapeutics, Inc. | 33 Million USD | 4.638% |
| MAIA Biotechnology, Inc. | 20.18 Million USD | -55.958% |
| Matinas BioPharma Holdings, Inc. | 24.86 Million USD | -26.603% |
| Navidea Biopharmaceuticals, Inc. | 13.93 Million USD | -125.933% |
| NovaBay Pharmaceuticals, Inc. | 12.89 Million USD | -144.038% |
| NanoViricides, Inc. | 8.51 Million USD | -269.606% |
| Oragenics, Inc. | 5.45 Million USD | -477.336% |
| BiomX Inc. | 26.81 Million USD | -17.387% |
| BiomX Inc. | 26.81 Million USD | -17.387% |
| Protalix BioTherapeutics, Inc. | 32.05 Million USD | 1.797% |
| Palatin Technologies, Inc. | 34.67 Million USD | 9.213% |
| Scorpius Holdings, Inc. | 39.81 Million USD | 20.946% |